Literature DB >> 21565671

Familial or genetic primary aldosteronism and Gordon syndrome.

Michael Stowasser1, Eduardo Pimenta, Richard D Gordon.   

Abstract

Salt-sensitive forms of hypertension have received considerable renewed attention in recent years. This article focuses on 2 main forms of salt-sensitive hypertension (familial or genetic primary aldosteronism [PA] and Gordon syndrome) and the current state of knowledge regarding their genetic bases. The glucocorticoid-remediable form of familial PA (familial hyperaldosteronism type I) is dealt with only briefly because it is covered in depth elsewhere.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565671     DOI: 10.1016/j.ecl.2011.01.007

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  5 in total

Review 1.  Primary aldosteronism in 2011: Towards a better understanding of causation and consequences.

Authors:  Michael Stowasser
Journal:  Nat Rev Endocrinol       Date:  2011-12-13       Impact factor: 43.330

Review 2.  Hyperaldosteronism: How to Discriminate Among Different Disease Forms?

Authors:  Valentina Crudo; Silvia Monticone; Jacopo Burrello; Fabrizio Buffolo; Martina Tetti; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-02

3.  Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits?

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

Review 4.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

5.  Pediatric endocrine hypertension.

Authors:  Nisha Bhavani
Journal:  Indian J Endocrinol Metab       Date:  2011-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.